{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-015654","form_type":"8-K","ticker":"PCSA","cik":"0001533743","company_name":"Processa Pharmaceuticals, Inc.","filed_at":"2025-06-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.656974+00:00","generated_at":"2026-05-19T02:53:39.190994+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Processa prices $7M public offering of common stock and warrants at $0.25/unit","bullets":["Gross proceeds of $7M before expenses; offering of 28M shares/pre-funded warrants plus 28M common warrants.","Combined price $0.25 per share (or pre-funded warrant) and accompanying common warrant.","Common warrants exercisable at $0.25/share for 5 years, immediately exercisable.","Net proceeds to fund Phase 2 trial of NGC-Cap and for working capital & general corporate purposes.","H.C. Wainwright acted as placement agent; receives 7% cash fee and 1.12M Placement Agent Warrants."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-015654","json":"https://secwatch.observer/filing/0001641172-25-015654.json","markdown":"https://secwatch.observer/filing/0001641172-25-015654.md","text":"https://secwatch.observer/filing/0001641172-25-015654.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1533743/000164117225015654/0001641172-25-015654-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1533743/000164117225015654/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T02:53:39.190994+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}